American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 677-682.e2 , April 2010

Incidence, Ocular Manifestations, and Survival in Children with Neuroblastoma: A Population-Based Study

  • Stephen J. Smith

      Affiliations

    • Mayo Clinic College of Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
    • ,
  • Nancy N. Diehl

      Affiliations

    • Mayo Clinic Division of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
    • ,
  • Brian D. Smith

      Affiliations

    • University of Rochester Department of Hematology/Oncology, University of Rochester, Rochester, New York
    • ,
  • Brian G. Mohney

      Affiliations

    • Mayo Clinic Department of Ophthalmology, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
    • Corresponding Author InformationInquiries to Brian G. Mohney, MD, Mayo Clinic, Department of Ophthalmology, 200 First St SW, Rochester, MN 55905

,Accepted 23 November 2009.

References 

  1. Ahmed S, Goel S, Khandwala M, Agrawal A, Chang B, Simmons IG. Neuroblastoma with orbital metastasis: Ophthalmic presentation and role of ophthalmologists. Eye. 2006;20:466–470
  2. Woods WG, Gao R-N, Shuster JJ, et al. Screening of infants and mortality due to neuroblastoma. N Engl J Med. 2002;346:1041–1046
  3. Bernstein ML, Leclerc JM, Bunin G, et al. A population-based study of neuroblastoma incidence, survival and mortality in North America. J Clin Oncol. 1992;10:323–329
  4. Castleberry RP. Biology and treatment of neuroblastoma. Pediatr Clin North Am. 1997;44:919–937
  5. Shields JA, Shields CL, Brotman HK, et al. Cancer metastatic to the orbit, The 2000 Robert M. Curts Lecture. Ophthal Plast and Reconstr Surg. 2001;17(5):346–354
  6. Belgaumi AF, Kauffman WM, Jenkins JJ, et al. Blindness in children with neuroblastoma. Cancer. 1997;80(10):1997–2004
  7. Musarella MA, Chan HS, DeBoer G, Gallie BL. Ocular involvement in neuroblastoma: prognostic implications. Ophthalmology. 1984;91:936–940
  8. Zafeiriou DI, Economou M, Koliouskas D, et al. Congenital Horner's syndrome associated with cervical neuroblastoma. Eur J Paediatr Neurol. 2006;10:90–92
  9. Saur C, Levinsohn MW. Horner's syndrome in childhood. Neurology. 1976;26:216–220
  10. Mahoney NR, Liu GT, Menacker SJ, et al. Pediatric Horner syndrome: Etiologies and roles of imaging and urine studies to detect neuroblastoma and other responsible mass lesions. Am J Ophthalmol. 2006;142:651–659
  11. Jeffery AR, Ellis FJ, Repka MX, Buncic JR. Pediatric Horner syndrome. J AAPOS. 1998;2:159–167
  12. Farrelly C, Daneman A, Chan H, Martin D. Occult neuroblastoma presenting with opsomyoclonus: utility of computed comography. AJR. 1984;142:807–810
  13. Alfano JE. Ophthalmological aspects of neuroblastomatosis: a study of 53 verified cases. Trans Am Acad Ophthalmol Otalaryngol. 1968;72:830–848
  14. Shubert EE, Oliver GL, Jaco NT. Metastatic neuroblastoma causing bilateral blindness. Can J Ophthalmol. 1969;4:100–103
  15. Kurland L, Molgaard CA. The patient record in epidemiology. Sci Am. 1981;245(4):54–63
  16. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  17. Horner MJ, Ries LAG, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975–2006. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Accessed November 15, 2009.
  18. Davis S, Rogers MAM, Pendergrass TW. The incidence and epidemiologic characteristics of neuroblastoma in the United States. Am J Epidemiol. 1987;126:1063–1074
  19. Carlsen NLT. Epidemiological investigations of neuroblastomas in Denmark 1943–1980. Br J Cancer. 1986;54:977–988
  20. Brodeur GM, Seeger RC, Barrett A, et al. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J Clin Oncol. 1988;6:1874–1881
  21. Weinstein JM, Zweifel TJ, Thompson HS. Congenital Horner syndrome. Arch Ophthalmol. 1980;98:1074–1078
  22. Wilhelm H, Ochsner H, Kopycziok E, et al. Horner's syndrome: a retrospective analysis of 90 cases and recommendations for clinical handling. Ger J Ophthalmol. 1992;1:96–102
  23. Woodruff G, Buncic JR, Morin JD. Horner's syndrome in children. J Pediatr Ophthalmol Strabismus. 1988;25:40–44
  24. Jaffe N, Cassady JR, Filler RM, et al. Heterochromasia and Horner's syndrome associated with cervical and mediastinal neuroblastoma. J Pediatr. 1975;87:75–77
  25. Pang KK, Sousa CD, Lang B, Pike MG. A prospective study of the presentation and management of dancing eye syndrome/opsoclonus-myoclonus syndrome in the United Kingdom. Eur J Paediatr Neurol. Forthcoming.
  26. Blake J, Fitzpatrick C. Eye signs in neuroblastoma. Trans Ophthalmol Soc U K. 1972;92:825–833
  27. Carlsen NLT, Christensen IJ, Schroeder H, et al. Prognostic factors in neuroblastomas treated in Denmark from 1943 to 1980 (A statistical estimate of prognosis based on 253 cases). Cancer. 1986;58:2726
  28. Coldman AJ, Fryer CJH, Elwood JM, Sonley MJ. Neuroblastoma: Influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer. 1980;46:1896–1901
  29. Gutierrez JC, Fischer AC, Sola JE, Perez EA, Koniaris LG. Markedly improving survival of neuroblastom: a 30-year analysis of 1,646 patients. Pediatr Surg Int. 2007;23(7):636–646
  30. Breslwo N, McCann B. Statistical estimation of prognosis for children with neuroblastoma. Cancer Res. 1971;31:2098–2103
  31. Kaneko M, Tsuchida Y, Mugishima H, et al. Intensified chemotherapy increases the survival rates in patients with stage 4 neuroblastoma with MYCN amplification. J Pediatr Hematol Oncol. 2002;24(8):613–621

PII: S0002-9394(09)00891-5

doi: 10.1016/j.ajo.2009.11.027

American Journal of Ophthalmology
Volume 149, Issue 4 , Pages 677-682.e2 , April 2010

Article Tools

* Image Usage & Resolution